v1
Phase III Rituxan/BEAM vs. Bexxar/BEAM With Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-cell Non-Hodgkin's Lymphoma (BMT CTN #0401)
Identifier:nobleid.org/w1/20260515/6F2CDAB4
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/6F2CDAB4)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims